Abstract

Although epidemiological studies have shown a relationship between periodontal disease and pancreatic cancer, the molecular mechanisms involved remain unclear. In this study, the effects of systemic administration of Porphyromonas gingivalis lipopolysaccharide (PG-LPS) on gene expression were comprehensively explored in mouse pancreas that did not demonstrate any signs of inflammation. PG-LPS was prepared in physiological saline and intraperitoneally administered to male mice at a concentration of 5 mg/kg every 3 days for 1 month. After extracting total RNA from the excised mice pancreas, a comprehensive DNA microarray analysis of gene expression was performed. Tissue specimens were also subjected to hematoxylin–eosin staining and immunohistochemistry using anti-regenerating islet-derived 3A and G (Reg3A/G) antibody. ImageJ software was used to quantify the area of Reg3A/G positive cells in pancreatic islets by binarizing image date followed by area extraction. The results were compared using Mann–Whitney U test. Data are presented as mean ± standard deviation (SD) with p < 0.05 considered as significant. Reg3G, a gene related to pancreatic cancer, was one of the 10 genes with the highest levels of expression in the pancreas stimulated with PG-LPS. The comprehensive analysis revealed a 73-fold increase in Reg3G expression level in the PG-LPS group when compared with the control group; in addition, the expression level of Reg3A was increased by 11-fold in the PG-LPS group. Image analysis showed that the ratio of Reg3A/G positive cells was higher in the PG-LPS group than the control. Immunostaining showed the presence of Reg3A/G-positive cells in the alpha-cell equivalent areas around the islets of Langerhans in the PG-LPS group. These results support the notion that periodontal disease may be a risk factor for pancreatic cancer.

Highlights

  • Growing evidence suggests that periodontal disease may be a risk factor for various systemic conditions, such as diabetes, respiratory disease, infectious endocarditis, autoimmune diseases, and chronic kidney disease [1,2,3,4]

  • A recent large-scale cohort study found that anti-Porphyromonas gingivalis (P. gingivalis) antibody titers were higher in pancreatic cancer patients than in healthy subjects, thereby suggesting that periodontal disease might be involved in pancreatic cancer [5]

  • We previously developed a mouse model that is unaffected by acute inflammation with P. gingivalis lipopolysaccharide (PG-LPS) to observe the effect of LPS on the kidney [12]

Read more

Summary

Introduction

Growing evidence suggests that periodontal disease may be a risk factor for various systemic conditions, such as diabetes, respiratory disease, infectious endocarditis, autoimmune diseases, and chronic kidney disease [1,2,3,4]. A recent large-scale cohort study found that anti-Porphyromonas gingivalis (P. gingivalis) antibody titers were higher in pancreatic cancer patients than in healthy subjects, thereby suggesting that periodontal disease might be involved in pancreatic cancer [5]. The molecular mechanisms in periodontal disease that may be related to pancreatic cancer have not been identified so far. Chronic pancreatitis and environmental factors such as alcohol consumption and obesity have been identified as potential risk factors for pancreatic cancer [6]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call